Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Management of Blood Pressure in CKD

Taler, Sandra J. ; Agarwal, Rajiv ; Bakris, George L. ; Flynn, Joseph T. ; Nilsson, Peter LU ; Rahman, Mahboob ; Sanders, Paul W. ; Textor, Stephen C. ; Weir, Matthew R. and Townsend, Raymond R. (2013) In American Journal of Kidney Diseases 62(2). p.201-213
Abstract
In response to the 2012 KDIGO (Kidney Disease: Improving Global Outcomes) guideline for blood pressure management in patients with chronic kidney disease not on dialysis, the National Kidney Foundation organized a group of US experts in hypertension and transplant nephrology to review the recommendations and comment on their relevancy in the context of current US clinical practice and concerns. The overriding message was the dearth of clinical trial evidence to provide strong evidence-based recommendations. For patients with CKD with normal to mildly increased albuminuria, goal blood pressure has been relaxed to <= 140/90 mm Hg for both diabetic and nondiabetic patients. In contrast, KDIGO continues to recommend goal blood pressure... (More)
In response to the 2012 KDIGO (Kidney Disease: Improving Global Outcomes) guideline for blood pressure management in patients with chronic kidney disease not on dialysis, the National Kidney Foundation organized a group of US experts in hypertension and transplant nephrology to review the recommendations and comment on their relevancy in the context of current US clinical practice and concerns. The overriding message was the dearth of clinical trial evidence to provide strong evidence-based recommendations. For patients with CKD with normal to mildly increased albuminuria, goal blood pressure has been relaxed to <= 140/90 mm Hg for both diabetic and nondiabetic patients. In contrast, KDIGO continues to recommend goal blood pressure <= 130/80 mm Hg for patients with chronic kidney disease with moderately or severely increased albuminuria and for all renal transplant recipients regardless of the presence of proteinuria, without supporting data. The expert panel thought the KDIGO recommendations were generally reasonable but lacking in sufficient evidence support and that additional studies are greatly needed. (C) 2013 by the National Kidney Foundation, Inc. (Less)
Please use this url to cite or link to this publication:
author
; ; ; ; ; ; ; ; and
organization
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Kidney Disease: Improving Global Outcomes (KDIGO), guideline, blood, pressure
in
American Journal of Kidney Diseases
volume
62
issue
2
pages
201 - 213
publisher
Elsevier
external identifiers
  • wos:000322784700002
  • scopus:84880644910
  • pmid:23684145
ISSN
1523-6838
DOI
10.1053/j.ajkd.2013.03.018
language
English
LU publication?
yes
id
1b4d3f96-27ad-4433-8dcf-c47f2466fd81 (old id 4033597)
date added to LUP
2016-04-01 10:10:53
date last changed
2022-04-12 02:39:34
@misc{1b4d3f96-27ad-4433-8dcf-c47f2466fd81,
  abstract     = {{In response to the 2012 KDIGO (Kidney Disease: Improving Global Outcomes) guideline for blood pressure management in patients with chronic kidney disease not on dialysis, the National Kidney Foundation organized a group of US experts in hypertension and transplant nephrology to review the recommendations and comment on their relevancy in the context of current US clinical practice and concerns. The overriding message was the dearth of clinical trial evidence to provide strong evidence-based recommendations. For patients with CKD with normal to mildly increased albuminuria, goal blood pressure has been relaxed to &lt;= 140/90 mm Hg for both diabetic and nondiabetic patients. In contrast, KDIGO continues to recommend goal blood pressure &lt;= 130/80 mm Hg for patients with chronic kidney disease with moderately or severely increased albuminuria and for all renal transplant recipients regardless of the presence of proteinuria, without supporting data. The expert panel thought the KDIGO recommendations were generally reasonable but lacking in sufficient evidence support and that additional studies are greatly needed. (C) 2013 by the National Kidney Foundation, Inc.}},
  author       = {{Taler, Sandra J. and Agarwal, Rajiv and Bakris, George L. and Flynn, Joseph T. and Nilsson, Peter and Rahman, Mahboob and Sanders, Paul W. and Textor, Stephen C. and Weir, Matthew R. and Townsend, Raymond R.}},
  issn         = {{1523-6838}},
  keywords     = {{Kidney Disease: Improving Global Outcomes (KDIGO); guideline; blood; pressure}},
  language     = {{eng}},
  number       = {{2}},
  pages        = {{201--213}},
  publisher    = {{Elsevier}},
  series       = {{American Journal of Kidney Diseases}},
  title        = {{KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Management of Blood Pressure in CKD}},
  url          = {{http://dx.doi.org/10.1053/j.ajkd.2013.03.018}},
  doi          = {{10.1053/j.ajkd.2013.03.018}},
  volume       = {{62}},
  year         = {{2013}},
}